Free tool
FAERS Monitor: Codeine Sulfate
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022402 or its brand name (Codeine Sulfate, Codeine Sulfate). Reports on generic versions are filed under their own applications.
Reports
3,309
Serious
2,121
64% of reports
Hospitalization
668
Death reported
799
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug hypersensitivity817
- nausea506
- drug ineffective400
- malaise380
- vomiting373
- headache371
- arthralgia363
- diarrhoea352
- dyspnoea338
- fatigue310
- cough309
- pain286
- pruritus273
- abdominal pain upper271
- off label use267
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 8 |
| 2005 | 1 |
| 2007 | 1 |
| 2009 | 21 |
| 2010 | 233 |
| 2011 | 387 |
| 2012 | 501 |
| 2013 | 154 |
| 2014 | 232 |
| 2015 | 102 |
| 2016 | 122 |
| 2017 | 144 |
| 2018 | 156 |
| 2019 | 243 |
| 2020 | 154 |
| 2021 | 120 |
| 2022 | 200 |
| 2023 | 140 |
| 2024 | 201 |
| 2025 | 131 |
| 2026 | 58 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,850 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug hypersensitivitySignal | 817 | 26.9 | 25.4 | 20,486 |
| abdominal pain upperSignal | 271 | 8.4 | 7.5 | 1,768 |
| coughSignal | 309 | 7.0 | 6.3 | 1,606 |
| arthralgiaSignal | 363 | 5.6 | 5.0 | 1,377 |
| malaiseSignal | 380 | 5.5 | 5.0 | 1,427 |
| vomitingSignal | 373 | 5.0 | 4.6 | 1,233 |
| pruritusSignal | 273 | 4.5 | 4.0 | 758 |
| nauseaSignal | 506 | 4.1 | 3.8 | 1,211 |
| dyspnoeaSignal | 338 | 3.8 | 3.4 | 712 |
| headacheSignal | 371 | 3.8 | 3.4 | 772 |
| diarrhoeaSignal | 352 | 3.5 | 3.1 | 635 |
| painSignal | 286 | 3.0 | 2.6 | 380 |
| fatigueSignal | 310 | 2.5 | 2.3 | 297 |
| off label use | 267 | 1.9 | 1.7 | 126 |
| drug ineffective | 400 | 1.9 | 1.8 | 190 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.